Ruo Qi Li
Overview
Explore the profile of Ruo Qi Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
21
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li R, Yan L, Zhang L, Ma H, Wang H, Bu P, et al.
Sci Rep
. 2024 May;
14(1):12386.
PMID: 38811720
Triple-negative breast cancer (TNBC) has high heterogeneity, poor prognosis, and limited treatment success. Recently, an immunohistochemistry-based surrogate classification for the "Fudan University Shanghai Cancer Center (FUSCC) subtyping" has been developed...
2.
Zheng S, Feng Y, Zhu Q, Li R, Yan Q, Teng L, et al.
Cancer Res
. 2024 Apr;
84(9):1460-1474.
PMID: 38593213
Significance: LncRNA MILIP plays a key role in supporting protein production in TNBC by forming complexes with tRNAs and eEF1α1, which confers sensitivity to combined MILIP targeting and protein synthesis...
3.
Li R, Yan L, Zhang L, Zhao Y, Lian J
Sci Rep
. 2024 Apr;
14(1):8125.
PMID: 38582956
CD74 is a type-II transmembrane glycoprotein that has been linked to tumorigenesis. However, this association was based only on phenotypic studies, and, to date, no in-depth mechanistic studies have been...
4.
Li R, Zhao X, Zhu Q, Liu T, Hondermarck H, Thorne R, et al.
Theranostics
. 2023 Feb;
13(3):1109-1129.
PMID: 36793869
While psychological factors have long been linked to breast cancer pathogenesis and outcomes, accumulating evidence is revealing how the nervous system contributes to breast cancer development, progression, and treatment resistance....
5.
Li R, Wang W, Yan L, Song L, Guan X, Zhang W, et al.
Front Oncol
. 2022 Oct;
12:973712.
PMID: 36226063
Background: Poor prognosis, resistance to chemotherapy, insensitivity to radiotherapy, and a high prevalence of adverse drug reactions remain urgent issues for breast cancer (BC) patients. Increased knowledge of tumor immunobiology...
6.
Li D, Hu L, Zheng S, La T, Wei L, Zhang X, et al.
FASEB Bioadv
. 2022 Jun;
4(6):391-401.
PMID: 35664834
Active crosstalk between the nervous system and breast cancer cells has been experimentally demonstrated in vitro and in animal models. However, low frequencies of peripheral nerve presence in human breast...